Skip to content
10-Q

Quarterly Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000824

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Stockholders Equity Q1 2021 · Dec 31, 2020 −$257.45K
Stockholders Equity Q1 2021 · Sep 30, 2020 −$250.1K
Current Liabilities Q1 2021 · Dec 31, 2020 $257.83K
Current Liabilities Q1 2021 · Sep 30, 2020 $250.5K
Total Liabilities Q1 2021 · Dec 31, 2020 $257.83K
Total Liabilities Q1 2021 · Sep 30, 2020 $250.5K
Current Assets Q1 2021 · Dec 31, 2020 $378
Current Assets Q1 2021 · Sep 30, 2020 $408
Total Assets Q1 2021 · Dec 31, 2020 $378
Total Assets Q1 2021 · Sep 30, 2020 $408
Net Income Q1 2021 · Dec 31, 2020 −$7.35K
Operating Cash Flow Q1 2021 · Dec 31, 2019 −$29
Operating Income Q1 2021 · Dec 31, 2019 −$1.14K